Showing posts with label Celgene. Show all posts
Showing posts with label Celgene. Show all posts

Thursday, August 20, 2009

Biopharma is on the move this week

This recent post on CNBC discusses how there has many major moves in the Biopharma industry this week and this has been good for many that hold biopharma stocks. Some of the major moves in the biopharma space include the following:


Human Genome Sciences and Orexigen showed their Lupus and diet drug data.

Onyx Pharmaceuticals was a surprise guest with its mid-stage breast cancer results on Wednesday.

Celgene announced it had stopped a multiple myeloma study early because the drug appears to be working so well.

Will next week be just as exciting in the biopharma industry/


Share this article with your social network, just click below to share now!


Wednesday, July 29, 2009

All Your Sample Storage Answers, All in One Location

Biorepositories 2009 facilitates interaction and networking with the industry’s top thought leaders. Bring your most pressing concerns, challenges, and questions to share during the interactive panel discussions including:

NCI and FDA representatives address biorepository standardization issues and regulatory challenges.

How to effectively collaborate with academics, hospitals, and non-profit organizations to increase your sample collection and expand your access to patient populations.

Millennium and Amylin focus on outsourcing strategies including best practices for evaluating service providers and building effective vendor relationships.

Go green in your biorepository – bring home solutions to reduce your footprint and maximize energy efficiency while still maintaining sample integrity.

Celgene and Axogen tackle transportation challenges to ensure sample safety and quality are top priorities when moving your fragile specimen samples.

Take advantage of this fantastic networking opportunity and be ready to bring home fresh ideas to implement in your organization. Register before August 7th and save $300!See you in September!

If you're interested in networking with other professionals in the biorepository field, join us here at the Biorepositories LinkedIn Group!


Share this article with your social network, just click below to share now!


Thursday, July 16, 2009

Global Congress on Comparator Studies

This is a reminder that the Global Congress on Comparator Studies conference kicks off on Monday in Philadelphia. There is still time to register if you’re interested in integrating a comprehensive blueprint for your comparator studies. Get your comparator studies up to standards before the new administration mandates it.

A selection of confirmed attendees:
Allergan Inc * Almac Clinical Services * Bernstein CMC Regulatory Consulting * Celgene * Cerexa Inc * Eli Lilly & Co * Facet Biotech Corporation * Farma Mondo SA * GlaxoSmithKline * Hospira Inc * Human Genome Sciences Inc * Merck & Company Inc * Multipharma Inc * Mylan Pharmaceuticals Inc * Myoderm Medical * Pfizer * Schering Plough Corporation * Takeda Pharmaceuticals North America Inc * Wyeth Pharmaceuticals

Global Congress on Comparator Studies 2009 is offering a terrific three day conference to amalgamate with industry thought leaders, network with colleagues and develop relationships with industry professionals. Join us to hear insight into how industry leaders are minimizing operational, regulatory and financial risks.


Share this article with your social network, just click below to share now!